Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-08-01, Stock:PFE, The news for the past five days is as follows:
2019-07-25: NEWS1: Bristol-Myers (BMY) Beats on Q2 Earnings & Sales, Raises View.NEWS2: Bristol-Myers (BMY) Beats on Q2 Earnings & Sales, Raises View.NEWS3: Glaxo (GSK) Beats on Q2 Earnings, Shingrix Sales Strong.NEWS4: Glaxo (GSK) Beats on Q2 Earnings, Shingrix Sales Strong.NEWS5: Bristol-Myers (BMY) Beats on Q2 Earnings & Sales, Raises View.NEWS6: Glaxo (GSK) Beats on Q2 Earnings, Shingrix Sales Strong.NEWS7: Health Care Sector Update for 07/25/2019: GEMP, QGEN, AZN, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Health Care Sector Update for 07/25/2019: GEMP, QGEN, AZN, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Can Pfizer's Q2 Earnings Help Boost PFE Stock in a Struggling Pharma Market?.NEWS10: Can Pfizer's Q2 Earnings Help Boost PFE Stock in a Struggling Pharma Market?.
2019-07-26: NEWS1: What's in the Cards for Pfizer (PFE) This Earnings Season?.NEWS2: What's in the Cards for Pfizer (PFE) This Earnings Season?.NEWS3: Can Newer Drugs Help Amgen (AMGN) Beat on Earnings in Q2?.NEWS4: Can Newer Drugs Help Amgen (AMGN) Beat on Earnings in Q2?.NEWS5: What's in the Cards for Pfizer (PFE) This Earnings Season?.NEWS6: Pharma Stock Roundup: GSK, BMY Q2 Earnings, FDA Nod to LLY's Hypoglycemia Treatment.NEWS7: Pharma Stock Roundup: GSK, BMY Q2 Earnings, FDA Nod to LLY's Hypoglycemia Treatment.NEWS8: Can Newer Drugs Help Amgen (AMGN) Beat on Earnings in Q2?.NEWS9: Senate advances bill to cut the cost of prescriptions.NEWS10: 3 Cancer Treatment Stocks to Buy Right Now.NEWS11: 3 Cancer Treatment Stocks to Buy Right Now.NEWS12: Array Acquisition Could Be a Huge Win for Pfizer, Analyst Says.NEWS13: Validea James P. O'Shaughnessy Strategy Daily Upgrade Report - 7/26/2019.NEWS14: Validea James P. O'Shaughnessy Strategy Daily Upgrade Report - 7/26/2019.
2019-07-29: NEWS1: Pfizer-Mylan Deal 'Well-Valued' for Mylan, Says Raffat.NEWS2: US Indexes Close Mostly Lower on Monday.NEWS3: UPDATE 2-J&J says FTC probing efforts to protect arthritis drug Remicade.NEWS4: GRAPHIC-Mylan stock boost follows long share struggles for company, generics industry.NEWS5: What Happened in the Stock Market Today.NEWS6: Mylan's Mixed 2nd-Quarter Results Overshadowed by News of Its Upjohn Merger.NEWS7: Mylan's Mixed 2nd-Quarter Results Overshadowed by News of Its Upjohn Merger.NEWS8: Dow Jones Today: Fed Watch Begins.NEWS9: US STOCKS-U.S. stocks back off record highs ahead of Fed meeting.NEWS10: Dow Jones Leads Stock Market As Apple, Disney Score Gains.NEWS11: Pre-Market Earnings Report for July 30, 2019 :  PG, MA, PFE, MRK, LLY, MO, COP, ECL, MMC, HCA, ETN, PEG.NEWS12: Pre-Market Earnings Report for July 30, 2019 :  PG, MA, PFE, MRK, LLY, MO, COP, ECL, MMC, HCA, ETN, PEG.NEWS13: Merger Fever Runs Hot In Pharma: Viagra, Epipen Sellers Announce Matchup.NEWS14: US Stock Market Overview &#8211; Stock Trade Mixed Ahead Central Bank Decisions.NEWS15: What You'll Want to Know About Pfizer's Q2 Earnings Results.NEWS16: What You'll Want to Know About Pfizer's Q2 Earnings Results.NEWS17: Mylan (MYL) Beats on Q2 Earnings, Inks Deal with Pfizer.NEWS18: Bresch would stand to gain a lot with Mylan's change in control, according to proxy.NEWS19: Why Is Pfizer Stock Down Despite the Deal With Mylan? Look at the Numbers..NEWS20: Mylan's Mixed 2nd-Quarter Results Overshadowed by News of Its Upjohn Merger.NEWS21: Pfizer to Combine Off-Patent Drug Business With Mylan.NEWS22: Mylan Inc. -- Moody's affirms Mylan's Baa3 ratings; outlook stable.NEWS23: Mylan N.V. -- Moody's affirms Mylan's Baa3 ratings; outlook stable.NEWS24: Health Care Sector Update for 07/29/2019: RDY,MYL,PFE,EXAS,GHDX.NEWS25: Health Care Sector Update for 07/29/2019: RDY,MYL,PFE,EXAS,GHDX.NEWS26: US STOCKS-Wall Street mixed as Amazon, Facebook weigh.NEWS27: What You'll Want to Know About Pfizer's Q2 Earnings Results.NEWS28: Why Mylan Stock Is Jumping Today.NEWS29: Why Mylan Stock Is Jumping Today.NEWS30: Mylan’s Mastermind Clutches the Reins as Pfizer Makes Its Move.NEWS31: Meet the CEO-in-waiting of the Mylan-Upjohn company.NEWS32: Pharmacia Corporation (Old Monsanto) -- Moody's reviews Pfizer's A1 rating for downgrade; affirms P-1 rating.NEWS33: US STOCKS-Wall Street mixed as Amazon, Facebook weigh.NEWS34: Mylan-Pfizer Deal: MYL Stock Soars on Off-Patent Drug Merger.NEWS35: Pfizer (PFE) Beats on Q2 Earnings, to Merge Upjohn With Mylan.NEWS36: Pfizer (PFE) Beats on Q2 Earnings, to Merge Upjohn With Mylan.NEWS37: Stock Market News: Pfizer and Mylan Make a Deal; Chipotle Looks Tasty.NEWS38: Stock Market News: Pfizer and Mylan Make a Deal; Chipotle Looks Tasty.NEWS39: Why Mylan Stock Is Jumping Today.NEWS40: Wall Street is not exactly impressed with the Pfizer-Mylan deal.NEWS41: What's in Store for Array BioPharma (ARRY) in Q4 Earnings?.NEWS42: What's in Store for Array BioPharma (ARRY) in Q4 Earnings?.NEWS43: UPDATE 1-Pfizer in talks to transition EpiPen maker into generics spinoff -spokeswoman.NEWS44: Pfizer Closes in on a Major Spinoff.NEWS45: Pfizer Closes in on a Major Spinoff.NEWS46: Dow Movers: PFE, MRK.NEWS47: Dow Movers: PFE, MRK.NEWS48: Buy Pfizer Stock Before this Week’s Earnings Report Gives It a Bump Up.NEWS49: Buy Pfizer Stock Before this Week’s Earnings Report Gives It a Bump Up.NEWS50: Stock Market News: Pfizer and Mylan Make a Deal; Chipotle Looks Tasty.NEWS51: While No Magic Pill, Mylan Deal Might Just Revive Drugmaker.NEWS52: Pfizer (PFE) Beats on Q2 Earnings, to Merge Upjohn With Mylan.NEWS53: US STOCKS-Wall St eases from record highs as tech drags; Fed meeting eyed.NEWS54: Pfizer in talks to transition EpiPen manufacturing into generics spinoff.NEWS55: Pfizer Falls 3%.NEWS56: Pfizer Reports Mixed Q2 Earnings, Lowers Guidance.NEWS57: For Mylan, it's bye-bye Netherlands, but Canonsburg's future role still unclear.NEWS58: It's Market Madness: Jim Cramer on Earnings Season, Pfizer and Mylan, Starbucks.NEWS59: US STOCKS-Wall Street falls as tech drags; Fed meeting eyed.NEWS60: S&P downgrades Pfizer by one notch to AA-minus after Upjohn/Mylan deal.NEWS61: What's in Store for Array BioPharma (ARRY) in Q4 Earnings?.NEWS62: Pfizer to Braid Old Blockbusters Into Mylan, Reshaping Industry.NEWS63: Health Care Sector Update for 07/29/2019: MYL, EXAS, GHDX, SNY, JNJ, PFE, MRK, ABT, AMGN.NEWS64: Health Care Sector Update for 07/29/2019: MYL, EXAS, GHDX, SNY, JNJ, PFE, MRK, ABT, AMGN.NEWS65: Stocks - Mylan, Uber Rise Premarket; Pfizer, Domino’s Fall.NEWS66: Generic drug maker stocks rally after Mylan deal to merge with Pfizer's Upjohn.NEWS67: The Dow Is Inching Higher, While Pfizer and Starbucks Are Falling.NEWS68: Pfizer Closes in on a Major Spinoff.NEWS69: US STOCKS-Wall St set to open flat as Fed policy meeting looms.NEWS70: Market Morning: Siri Hears Drug Deals, Sex; Alibaba Banks On Bank, Google Gets Gabbarded, Mylan & Pfizer Unite.NEWS71: 3 Things to Look For in Pfizer's Q2 Earnings Update.NEWS72: 3 Things to Look For in Pfizer's Q2 Earnings Update.NEWS73: Pfizer (PFE) Q2 Earnings Top Estimates.NEWS74: Pfizer (PFE) Q2 Earnings Top Estimates.NEWS75: Pfizer stock down after revenue miss, merger announcement.NEWS76: Pre-Market Most Active for Jul 29, 2019 :  MYL, TEVA, NOK, PFE, LXRX, AMD, YNDX, AZN, STM, GHDX, TVIX, ABB.NEWS77: Pre-Market Most Active for Jul 29, 2019 :  MYL, TEVA, NOK, PFE, LXRX, AMD, YNDX, AZN, STM, GHDX, TVIX, ABB.NEWS78: Mylan Shares Soar on Merger News, but Pfizer’s Stock Is Sagging.NEWS79: Futures flat as Fed policy meeting looms.NEWS80: Pfizer (PFE) Q2 Earnings Top Estimates.NEWS81: Mylan, Pfizer's Upjohn To Merge And Create New Company.NEWS82: Pfizer and Mylan: Is Mega-Merger on the Horizon?.NEWS83: Pfizer and Mylan to combine off-patent drugs businesses.NEWS84: Mylan CEO Heather Bresch to retire after deal to merge with Pfizer's Upjohn closes.NEWS85: Pfizer-Mylan Generic Giant Solves Two Problems With One Deal.NEWS86: Mylan to merge with Upjohn in new company.NEWS87: Pfizer to spinoff, merge off-patent drugs unit with Mylan.NEWS88: Mylan beats adjusted profit, revenue expectations.NEWS89: Pfizer posts 30% rise in quarterly profit.NEWS90: Mylan's stock soars after merger deal with Pfizer's Upjohn.NEWS91: Pfizer Inc. Reschedules Second-Quarter 2019 Earnings Conference Call to July 29, 2019 at 10:30 a.m. EDT.NEWS92: PFIZER REPORTS SECOND-QUARTER 2019 RESULTS .NEWS93: Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World’s Need for Medicine.NEWS94: Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World's Need for Medicine.NEWS95: 3 Things to Look For in Pfizer&apos;s Q2 Earnings Update.NEWS96: Pfizer to Combine Off-Patent Drug Division With Mylan.NEWS97: Stocks - U.S. Futures Flat as U.S.-China Trade Talks Recommence.NEWS98: Beyond Meat, Pfizer, Mylan, Amazon, Federal Reserve - 5 Things You Must Know.NEWS99: Mylan Shares Surge Amid Reports of Off-Patent Drug Combination with Pfizer.NEWS100: PRESS DIGEST- New York Times business news - July 29.
2019-07-30: NEWS1: Edited Transcript of PFE earnings conference call or presentation 29-Jul-19 2:30pm GMT.NEWS2: US Indexes Close Mostly Lower Tuesday.NEWS3: Why Beyond Meat, McDermott International, and Pfizer Slumped Today.NEWS4: Why Beyond Meat, McDermott International, and Pfizer Slumped Today.NEWS5: Trade Tweets, Pfizer Drag On Dow.NEWS6: Trade Tweets, Pfizer Drag On Dow.NEWS7: Market Close Report: NASDAQ Composite index closes at 8,273.61 down -19.72 points.NEWS8: Market Close Report: NASDAQ Composite index closes at 8,273.61 down -19.72 points.NEWS9: US STOCKS-Tech pulls Wall Street lower on Trump trade warning.NEWS10: Why Beyond Meat, McDermott International, and Pfizer Slumped Today.NEWS11: Dow Jones Today: Trump Trade Tweets at It Again.NEWS12: US STOCKS-Wall Street drops on new trade worries, Fed; Apple eyed.NEWS13: Stock Market Pares Losses; Apple Improves Ahead Of Earnings.NEWS14: Tuesday's ETF with Unusual Volume: SIZE.NEWS15: Tuesday's ETF with Unusual Volume: SIZE.NEWS16: Notable Tuesday Option Activity: LEG, PFE, DIS.NEWS17: Notable Tuesday Option Activity: LEG, PFE, DIS.NEWS18: Pfizer Becomes a Falling Knife After Monday's Earnings.NEWS19: Dow Still Underwater As Pfizer Stock Slammed; Will Apple Earnings Beat?.NEWS20: Busy Morning for Investors: Trade, Data, Earnings for PFE, MRK, COP & More.NEWS21: Busy Morning for Investors: Trade, Data, Earnings for PFE, MRK, COP & More.NEWS22: Merck Shares Rise on Strong Sales Growth.NEWS23: Economic and Earnings Date Deluge.NEWS24: Economic and Earnings Date Deluge.NEWS25: Ex-Dividend Reminder: CMS Energy, Pfizer and Atlantic Union Bankshares.NEWS26: Ex-Dividend Reminder: CMS Energy, Pfizer and Atlantic Union Bankshares.NEWS27: DGRO, VZ, PFE, MRK: Large Outflows Detected at ETF.NEWS28: DGRO, VZ, PFE, MRK: Large Outflows Detected at ETF.NEWS29: Relative Strength Alert For Pfizer.NEWS30: Relative Strength Alert For Pfizer.NEWS31: How Big Is Pfizer's Generic Drugs Business That It Plans To Merge With Mylan?.NEWS32: How Big Is Pfizer's Generic Drugs Business That It Plans To Merge With Mylan?.NEWS33: FTC investigating Johnson & Johnson's Remicade contracting practices.NEWS34: Morgan Stanley Downgrades Pfizer In Wake Of Upjohn-Mylan Merger.NEWS35: Stock Market News For Jul 30, 2019.NEWS36: Stock Market News For Jul 30, 2019.NEWS37: Dow Movers: PFE, PG.NEWS38: Dow Movers: PFE, PG.NEWS39: Pfizer Falls 7%.NEWS40: Economic and Earnings Date Deluge.NEWS41: Mylan reaches $30 million settlement in SEC's EpiPen probe.NEWS42: Busy Morning for Investors: Trade, Data, Earnings for PFE, MRK, COP & More.NEWS43: Pfizer Stock Falls for the Second Day After Mylan Deal.NEWS44: Pfizer's stock tumbles toward worst 2-day stretch in 10 1/2-years.NEWS45: Stock Market News For Jul 30, 2019.NEWS46: Health Care Sector Update for 07/30/2019: FMS, MRK, LLY, JNJ, PFE, ABT, AMGN.NEWS47: Health Care Sector Update for 07/30/2019: FMS, MRK, LLY, JNJ, PFE, ABT, AMGN.NEWS48: RPT-GRAPHIC-Mylan stock boost follows long share struggles for company, generics industry.NEWS49: US STOCKS-Wall St set to open lower as focus shifts to Fed meeting, Apple earnings.NEWS50: 3 Big Stock Charts for Tuesday: Hanesbrands, Tapestry and Travelers Companies.NEWS51: Pfizer Completes Acquisition of Array Biopharma.NEWS52: The 5 Worst S&P 500 Stocks Are Costing You $22.3 Billion; Here's Why.NEWS53: Challenges remain for Mylan despite merger with Upjohn.NEWS54: 3 Key Things to Know About How the Mylan-Upjohn Merger Affects Pfizer Shareholders.NEWS55: Mylan deal puts future of its beleaguered EpiPen in spotlight.NEWS56: Prey turns predator as LSE goes for Refinitiv.NEWS57: SHAREHOLDER ALERT: WeissLaw LLP Investigates Mylan N.V..
2019-07-31: NEWS1: 5 Stocks to Buy and Keep an Eye on Come Fall.NEWS2: 5 Stocks to Buy and Keep an Eye on Come Fall.NEWS3: Why Pfizer Stock Continues to Tank after Mylan Deal.NEWS4: Wednesday’s Vital Data: Pfizer, Advanced Micro Devices and Apple.NEWS5: Wednesday’s Vital Data: Pfizer, Advanced Micro Devices and Apple.NEWS6: 3 Big Stock Charts for Wednesday: Southern Co, CF Industries Holdings and National-Oilwell Varco.NEWS7: 3 Big Stock Charts for Wednesday: Southern Co, CF Industries Holdings and National-Oilwell Varco.NEWS8: Stocks - Stocks Dive as Fed's Powell Sinks Future Easing Hopes.NEWS9: Wednesday’s Vital Data: Pfizer, Advanced Micro Devices and Apple.NEWS10: Here’s How Pfizer Stock (and Pharma) Stand to Benefit From Mylan Deal.NEWS11: Here’s How Pfizer Stock (and Pharma) Stand to Benefit From Mylan Deal.NEWS12: Health Care Sector Update for 07/31/2019: HUM, TTOO, AMRN, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Health Care Sector Update for 07/31/2019: HUM, TTOO, AMRN, JNJ, PFE, ABT, MRK, AMGN.NEWS14: Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for August 01, 2019.NEWS15: Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for August 01, 2019.NEWS16: 3 Big Stock Charts for Wednesday: Southern Co, CF Industries Holdings and National-Oilwell Varco.NEWS17: Pfizer: Downgrade Double-Whammy On Mylan Deal.NEWS18: Here’s How Pfizer Stock (and Pharma) Stand to Benefit From Mylan Deal.

Answer: Decrease